Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 387Neoplasms 333Prostatic Neoplasms 188Lung Neoplasms 175Colorectal Neoplasms 142Motor Activity 87Pancreatic Neoplasms 73Uterine Cervical Neoplasms 70Brain Neoplasms 69Head and Neck Neoplasms 67Carcinoma, Non-Small-Cell Lung 63Ovarian Neoplasms 59Rectal Neoplasms 49Carcinoma, Hepatocellular 49Colonic Neoplasms 46Glioblastoma 42Anxiety Disorders 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Depression 39Neoplasm Metastasis 38Hematologic Neoplasms 37Melanoma 34Glioma 34Multiple Myeloma 33Disease 33Stomach Neoplasms 32Sarcoma 31Carcinoma, Renal Cell 30Urinary Bladder Neoplasms 29Pain 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Urinary Bladder, Overactive × 90 days × Clear all
NCT06511141 2026-05-12

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Axonics, Inc.

Phase NA Recruiting
150 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder, Overactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡